Mixed week for the markets around the world - Weekly Review, 18 – 22.05

Mixed week for the markets around the world - Weekly Review, 18 – 22.05

The hope of a vaccine pushed markets.

Monday: The beginning of the week was good for the markets: all benchmarks ended the trading session in the green. Moderna’s successful vaccine trial moved the markets. The most significant gains were by TECH100 and Germany30, which rose 3.85%, and 5.67%, respectively.

The short-selling ban for a handful of European countries ended.

Bank of Spain announced that the pandemic pushed the economy to set negative records. In just three months, the economy shrunk by 5.2%. The contraction is expected to increase by up to 12.4%.

Baidu had a better than expected Q1 report, as the pandemic forced people to stay indoors. In after-hours trading, the stock price went up 8%.

France and Germany have put together a monetary measure worth $545 billion debt-backed plan to help the most affected European countries get back on their feet.

Tuesday: Information about Moderna’s vaccine has surfaced and made the investors lose their trust. Benchmarks fell by 0.5% up to 1.59%.

The Chinese Central bank announced that it would keep the interest rate at 3.85% - HongKong45 lost 0.12%, while USD/CNY added 0.10%.

Gold added 0.44% to $1, 753.20 per ounce.

Walmart had a better than expected financial report. Due to the pandemic, online sales grew by 74%. In after-hours trading, it gained more than 3%.

Kohl’s Q1 report was disappointing. Unlike Walmart, it lost 43% in just three months. This year alone, the stock price fell by 63%.

Wednesday: Europe started to ease the lockdown measures, which made the benchmarks gain.

Japan225 lost 0.05% after the country’s exports collapsed during the pandemic.

Oil added 2.97% to $32.91 per barrel. Brent Oil rose 1.885 to $35.30 per barrel.

Gold lost what it gained on Tuesday, dropping by 0.49%.

Target had a good Q1, part of the pandemic, due to which the online services increased by 278%.

Thursday: The American benchmarks ended the day in red, with losses between 0.41% and 0.97%.

HongKong45 closed at 3.7% - reaching a seven-week low.

Also, the European benchmarks closed on negative: UK100 lost 0.9%, Italy40 dropped by 0.7%, while Germany30 shed 1.4%.

Ford had some problems when reopening some of the essential plants in the States. Some workers were found positive of infection. Until now, the stock fell 41%.

The unemployment report showed another 2.438 million jobless people. Since the lockdown, more than 38 million people are on unemployment benefits.

Friday: Japan225 gained 1.75 after the government announced a new potential stimulus package.

AstraZeneca announced sponsorship from the U.S. in its efforts to produce a viable vaccine against the virus. It has received $1 billion to push the gas-pedal in the developing process.

Alibaba posted their Q1 report, which exceeded analysts’ expectations. The revenue grew by 22% compared to the same time last year.

Stay updated with the latest market news! Register now!

Sources: investing.com, edition.cnn.com, marketwatch.com, cnbc.com, seekingalpha.com


La información presentada aquí está preparada por CAPEX.com y no pretende constituir un asesoramiento de inversión. La información aquí se proporciona como una comunicación general de marketing con propósitos solo de información, y como tal, no se han preparado de acuerdo con los requisitos legales diseñados para promover la independencia de un estudio de inversión, y no está sujeto a ninguna prohibición para hacer frente con antelación a la diseminación de los análisis de inversión.

Los usuarios / lectores no deben confiar únicamente en la información presentada aquí y deben hacer su propia investigación / análisis leyendo también la investigación subyacente real. El contenido adjunto es genérico y no tiene en cuenta las circunstancias personales, la experiencia de inversión o la situación financiera actual.

Por lo tanto, Key Way Investments Ltd no aceptará ninguna responsabilidad por las pérdidas de los comerciantes debido al uso y el contenido de la información presentada en este documento. El rendimiento pasado no es un indicador confiable de resultados futuros.